Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patients.

[1]  S Friedman,et al.  The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  K. Griffiths,et al.  Predictive power of progesterone receptor status in early breast carcinoma , 1987, The British journal of surgery.

[3]  G. Bonadonna,et al.  Current status of adjuvant chemotherapy for breast cancer. , 1987, Seminars in oncology.

[4]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[5]  I. Ellis,et al.  Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. , 1987, British Journal of Cancer.

[6]  J. Schlom,et al.  Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. , 1986, Cancer research.

[7]  A. Howell,et al.  MECHANISM OF ACTION OF ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER , 1986, The Lancet.

[8]  C. Redmond,et al.  Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  T. Lemarchand-Béraud,et al.  The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women °clinical correlation on 547 patients , 1986, Cancer.

[10]  P. Gaglia,et al.  The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysis. , 1986, European journal of cancer & clinical oncology.

[11]  Fisher Er.  Prognostic and therapeutic significance of pathological features of breast cancer. , 1986 .

[12]  W. McGuire,et al.  Role of steroid hormone receptors as prognostic factors in primary breast cancer. , 1986, NCI monographs : a publication of the National Cancer Institute.

[13]  B. Rasmussen,et al.  Steroid hormone receptors as prognostic indicators in primary breast cancer. , 1986, Breast cancer research and treatment.

[14]  L. Dressler,et al.  Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. , 1985, Journal of the National Cancer Institute.

[15]  W. P. Reed,et al.  A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer. , 1985, Annals of surgery.

[16]  W D Dupont,et al.  Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading , 1984, Cancer.

[17]  Y. Collan,et al.  Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients. , 1984, Anticancer research.

[18]  R. Vihko,et al.  Oestrogen and progesterone receptors and disease-free interval in primary breast cancer. , 1984, British Journal of Cancer.

[19]  R. Bryan,et al.  Progesterone receptors in breast cancer. , 1984, The Australian and New Zealand journal of surgery.

[20]  S. Aamdal,et al.  Estrogen receptors and long‐term prognosis in breast cancer , 1984, Cancer.

[21]  D. Coradini,et al.  Prognostic Significance of Progesterone Receptors Alone or in Association with Estrogen Receptors in Human Breast Cancer , 1984, Tumori.

[22]  A. Howell,et al.  STEROID-HORMONE RECEPTORS AND SURVIVAL AFTER FIRST RELAPSE IN BREAST CANCER , 1984, The Lancet.

[23]  W. McGuire,et al.  Progesterone receptors as a prognostic factor in stage II breast cancer. , 1983, The New England journal of medicine.

[24]  E. Milgrom,et al.  [Quality control of the assay of receptors in human breast tumors]. , 1983, Pathologie-biologie.

[25]  R. Rubens,et al.  Steroid receptors and prognosis in operable (stage I and II) breast cancer. , 1983, European journal of cancer & clinical oncology.

[26]  P. Mullins,et al.  Progesterone and estrogen receptors as prognostic variables in breast cancer. , 1983, Cancer research.

[27]  D. Barnes,et al.  The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. , 1983, British Journal of Cancer.

[28]  P. Rosen,et al.  Estrogen receptor protein in breast cancer as a predictor of recurrence , 1981, Cancer.

[29]  B. Fineberg,et al.  Prognostic indicators in patients with isolated local–regional recurrence of breast cancer , 1981, Cancer.

[30]  A. Buzdar,et al.  Estrogen receptor: A prognostic factor in breast cancer , 1981, Cancer.

[31]  C. McArdle,et al.  Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. , 1981, British Journal of Cancer.

[32]  M Brunet,et al.  Relationship of presence of progesterone receptors to prognosis in early breast cancer. , 1980, Cancer research.

[33]  G. Hortobagyi,et al.  Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy , 1980, Cancer.

[34]  R. Hähnel,et al.  Prognostic value of estrogen receptors in primary breast cancer , 1979, Cancer.

[35]  R. Blamey,et al.  Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. , 1978, British Journal of Cancer.

[36]  E. J. Gregory,et al.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. , 1977, Cancer research.

[37]  D. Cox.  Regression Models and Life-Tables , 1972 .

[38]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.